Erik Tambuyzer

Therapies for rare diseases: therapeutic modalities, progress and challenges ahead

Tudor I. Oprea, Christopher P. Austin, Marco Prunotto, 2019, Nature Reviews Drug Discovery.

Acute coronary syndrome: What is the cost-effectiveness of prevention, point-of-care technology and telemonitoring?

Nuala Moran, Prateek Jain, Walter Van Dyck, 2012 .

Rare diseases, orphan drugs and their regulation: questions and misconceptions

E. Tambuyzer, Erik Tambuyzer, 2010, Nature Reviews Drug Discovery.

The need for worldwide policy and action plans for rare diseases

Domenica Taruscio, Désirée Gavhed, Manuel Posada, 2012, Acta paediatrica.